Effect of Calcium Channel Blockers on Vertebral Bone Marrow Perfusion of the Lumbar Spine

Radiology

Volumn 231, Issue 1, 2004, Pages 24-30

  Shih, Tiffany Ting Fang ^a   Chang, Chee Jen ^b   Tseng, Wen Yih Isaac ^a   Hsiao, Jong Kai ^a   Shen, Ling Chun ^a   Liu, Tsang Wu ^c   Yang, Pan Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Bone marrow, MR; Drugs, side effects; Magnetic resonance (MR), perfusion study; Spine, MR

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; NIFEDIPINE;

ADULT; ARTICLE; BLOOD FLOWMETRY; BLOOD PRESSURE MEASUREMENT; BONE MARROW; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG EFFECT; EVALUATION; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE ENHANCEMENT; LUMBAR SPINE; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; TISSUE PERFUSION; VERTEBRA; VERTEBRA BODY; WILCOXON SIGNED RANKS TEST;

ADULT; BLOOD PRESSURE; BONE MARROW; CALCIUM CHANNEL BLOCKERS; DIASTOLE; FEMALE; HEART RATE; HUMANS; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NIFEDIPINE; PERFUSION; RADIOGRAPHIC IMAGE ENHANCEMENT; REFERENCE VALUES; SEX FACTORS; STATISTICS, NONPARAMETRIC; SYSTOLE;

EID: 1642277245     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2311030382     Document Type: Article

References (32)

1. Laroche M. Arteriosclerose et osteoporose. Presse Med 1996; 25:52-54.
2. Demmler K, Otte P, Bartl R, Burkhardt R, Frisch B, Jahn A. Oateopenie, markatrophie und kapillarvewsorgung: vergleichende untersuchungen am menschlichen beckenkamm und 1 lendenwirbelkörper. Z Orthop 1983; 121:223-227.
3. Burkhardt R, Kettner G, Böhm W, et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 1987; 8:157-164.
4. Sim FH, Kelly PJ. Relationship of bone remodeling, oxygen consumption, and blood flow in bone. J Bone Joint Surg Am 1970; 52:1377-1389.
5. Reeve J, Arlot M, Wootton R, et al. Skeletal blood flow, iliac histomorphometry, and strontium kinetics in osteoporosis: a relationship between blood flow and corrected apposition rate. J Clin Endocrinol Metab 1988; 66:1124-1131.
6. Laroche M, Pouilles JM, Ribot C, et al. Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 1994; 13:611-614.
7. Laroche M, Ludot I, Thiechart M, et al. Study of the intraosseous vessels of the femoral head in patients with fractures of the femoral neck or osteoarthritis of the hip. Osteoporos Int 1995; 5:213-217.
8. Browner WS, Seeley DG, Vogt TM, Cummings SR. Non-trauma mortality in elderly women with low bone mineral density. Lancet 1991; 338:355-358.
9. Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR. Association between low bone density and stroke in elderly women: the study of osteoporotic fractures. Stroke 1993; 24:940-946.
10. Riggs BL, Melton LJ 3rd. Involutional osteoporosis. N Engl J Med 1986; 314:1676-1686.
11. Moon J, Bandy B, Davison AJ. Hypothesis: etiology of atherosclerosis and osteoporosis-are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr 1992; 11:567-583.
12. Oates JA, Brown NJ. Antihypertensive agents and the drug therapy of hypertension. In: Hardman JG, Limbird LE, Goodman Gilman A, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. New York, NY: McGraw-Hill Medical Publishing, 2000; 871-897.
13. Leier CV, Patrick TJ, Hermiller J, et al. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. Am Heart J 1984; 108:1461-1468.
14. Waite RP, Pang CC, Walker MJ. Effects of verapamil, nifedipine and flunarizine on haemodynamics and regional blood flows in pentobarbitone-anaesthetized rats. J Pharm Pharmacol 1990; 42:325-331.
15. Burggraaf J, Schoemaker RC, Kroon JM, Cohen AF. The influence of nifedipine and captopril on liver blood flow in healthy subjects. Br J Clin Pharmacol 1998; 45:447-451.
16. Frohlich ED, McLoughlin MJ, Losem CJ, Ketelhut R, Messerli FH. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension. Am J Cardiol 1991; 68:1346-1350.
17. Wong F, Massie F, Hsu P, Dudley F. Nifedipine: its effects on renal hemodynamics and sodium homeostasis well-compensated alcoholic cirrhosis. J Hepatol 1994; 21:64-69.
18. Hungerford DS. Pathogenesis of ischemic necrosis of the femoral head. In: Proceedings of the Eleventh Open Scientific Meeting of the Hip Society. St Louis, Mo: Mosby, 1983.
19. Wilkes CH, Visscher MB. Some physiological aspects of bone marrow pressure. J Bone Joint Surg Am 1975; 57:49-57.
20. Cova M, Kang YS, Tsukamoto H, et al. Bone marrow perfusion evaluated with gadolinium-enhanced dynamic fast MR imaging in a dog model. Radiology 1991; 179:535-539.
21. Bluemke DA, Petri M, Zerhouni EA. Femoral head perfusion and composition: MR imaging and spectroscopic evaluation of patients with systemic lupus erythematosus and at risk for avascular necrosis. Radiology 1995; 197:433-438.
22. Verstraete KL, De Deene Y, Roels H, et al. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging-parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192:835-843.
23. Van Der Woude HJ, Bloem JL, Verstraete KL, et al. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR Am J Roentgenol 1995; 165:593-598.
24. Chen WT, Shih TT, Chen RC, et al. The blood perfusion of vertebral lesions evaluated with gadolinium-enhanced dynamic MR imaging: in comparison with compression fracture and metastasis. J Magn Reson Imaging 2002; 15:308-314.
25. Chen WT, Shih TT, Chen RC, et al. Vertebral bone marrow perfusion evaluated with dynamic contrast-enhanced MR imaging: significance of aging and sex. Radiology 2001; 220:213-218.
26. Brix G, Semmler W, Port R, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhancement MR imaging. J Comput Assist Tomogr 1991; 15:621-628.
27. Buckley DL, Kerslake RW, Blackband SJ, Horsman A. Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimization procedure. Magn Reson Med 1994; 32:646-651.
28. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7:91-101.
29. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10:223-232.
30. Hawighorst H, Libicher M, Knopp MV, et al. Evaluation of angiogenesis and perfusion of bone marrow lesions: role of semiquantitative and quantitative dynamic MRI. J Magn Reson Imaging 1999; 10: 286-294.
31. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995; 33:506-514.
32. Daniel BL, Yen YF, Glover GH, et al. Breast disease: dynamic spiral MR imaging. Radiology 1998; 209:499-509.